ArticleComputational and structural biotechnology journal2025
Three-dimensional, patient-specific simulation of cerebral blood flow velocities as a new approach for individualized stroke prevention and treatment.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Three-dimensional simulations of cerebral blood flow are a highly promising approach for individualized diagnostics and therapy planning in cerebrovascular disease. The aim of this study is to validate simulated blood flow velocities generated by a patient-specific model using the innovative Stroke Quantification software (StroQ, ELPIS Simulation GmbH, Germany). Methods: In this study, consecutive patients with transient ischemic attack (TIA) or minor ischemic stroke (defined as NIHSS ≤ 4) treated at a tertiary stroke center have been investigated. The patients underwent both computed tomography angiography (CTA) and neurovascular ultrasound (nvUS) of the extra- and intracranial arteries. Patients with relatively large artery atherosclerosis (LAA) such as significant plaques or stenosis are excluded in this study. 3D-models of the brain-supplying arteries were created using standard CTA with 0.75 mm slice thickness. Blood flow of the intracranial arteries was simulated using finite volume and fluid-structure interaction methods and employing nvUS-derived flow velocities and systemic blood pressure of the extracranial internal carotid arteries (ICA) and vertebral arteries (VA). The simulated flow velocities of all intracranial arteries were then compared to the transcranial color-coded duplex sonography TCCD-derived measurements using intraclass correlation coefficients, Pearson correlations, Bland-Altman, and scatter plots. Results: Patient-specific artery models were created for 53 consecutive ischemic stroke patients without relevant LAA. The results demonstrated a high accuracy between TCCD- and simulation-derived velocities for peak systolic velocities (PSV). Intraclass correlation coefficients were moderate for three arteries and good to excellent for all remaining intracranial arteries (ICC ≥ 0.750, p < 0.001). Overall, only small differences between simulation-derived velocities and TCCD were observed (PSV: mean difference -2.6 cm/s, -4.5 %, end-diastolic velocities (EDV): mean difference 0.5 cm/s, 1.4 % and mean flow velocity (MFV): mean difference -0.3 cm/s, -3.3 %). Pearson correlations between TCCD- and simulation-derived PSV, EDV and MFV velocities were significant for all intracranial arteries (p < 0.001). Conclusions: The study revealed accurate flow velocity values derived from the patient-specific artery simulation of the intracranial arteries as compared to the clinical gold standard represented by TCCD. Simulation of cerebral perfusion may support personalized medicine by helping to tailor blood pressure targets and guide decisions on invasive reperfusion strategies (e.g., carotid endarterectomy or stenting), based on individual vascular anatomy and physiological parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.